ASP Isotopes Inc. has acquired an independent radiopharmacy located in Florida, expanding the operations of PET Labs Pharmaceuticals (Pty) Ltd, its South African radiopharmaceutical business. This move marks PET Labs' first expansion outside South Africa and is part of a strategy to build a vertically integrated supply chain for radiopharmaceutical products. The acquisition is expected to contribute positively to the company's 2026 revenues, EBITDA, and EPS.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9544419-en) on October 13, 2025, and is solely responsible for the information contained therein.